As described in the Autism Strategic Plan for Science, our main goals are:
- Seek the causes and types of autism
- Lower the average age of diagnosis to under 2 years
- Expand services across the lifespan
- Enhance medical treatment of autism’s associated health conditions.
We pursue these goals through the following programs.
MSSNG provides autism researchers with free access to thousands of sequenced genomes from families affected by autism.
The goal: To speed the development of more effective and personalized interventions for autism and its associated health conditions.
MSSNG has grown into one of the world’s largest open-access genome databases.
More than 7,000 families have contributed their genetic material for sequencing. More than a hundred autism researchers are now analyzing this data.
We are also creating a MSSNG community portal. It will help participants understand the genetic variations that affect them. They can opt to connect with others affected by similar genes.
Learn more about MSSNG.
Global Autism Public Health
Through GAPH, Autism helps underserved communities meet the needs of the world’s growing autism population.
The goal: To deliver practical and culturally appropriate services that improve lives.
We do this through research and partnerships with families, researchers, advocacy groups and governments in more than 70 countries.
Autism helped develop the World Health Organization’s Caregiver Skills Training program. Our staff is now helping test and refine the program in a broad range of underserved communities in the United States and abroad.
Learn more about GAPH.
Predoctoral and Postdoctoral Fellowships
Autism’ research fellowships support groundbreaking research by early career investigators, under the guidance of the field’s leaders.
The goal: To launch the careers of highly promising autism researchers, while advancing research that improves lives.
Already, many of our fellows have made important discoveries about autism and how to better meet the needs of people on the spectrum.
Learn more about our research fellowships.
The Preclinical Autism Consortium for Therapeutics
In 2013, Autism established its Preclinical Autism Consortium for Therapeutics (PACT) to develop high-quality animal models of autism.
The goal: To speed the development of safer, more-effective medicines for people who have autism.
Currently, several pharmaceutical companies are interested in using PACT animal models to screen potential medicines for safety and benefits.
Learn more about PACT.
Autism Autism Treatment Network (ATN)
The Autism Autism Treatment Network (ATN) includes 12 of the finest medical centers in North America.
The goal: To improve the health of people with autism.
This includes improving diagnosis and treatment of the health conditions that often accompany autism. The ATN shares these best practices with physicians and medical facilities across North America and abroad.
The ATN receives federal funding to serve as the Autism Research Network for Physical Health (AIR-P). In this role, it conducts research and shares resources to meet the healthcare needs of the autism community. These resources include more than 20 ATN/AIR-P tool kits for families and medical professionals. Download yours.
Learn more about the Autism ATN.